184 related articles for article (PubMed ID: 18541028)
1. Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion.
Fu XD; Giretti MS; Goglia L; Flamini MI; Sanchez AM; Baldacci C; Garibaldi S; Sitruk-Ware R; Genazzani AR; Simoncini T
BMC Cancer; 2008 Jun; 8():166. PubMed ID: 18541028
[TBL] [Abstract][Full Text] [Related]
2. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton.
Fu XD; Giretti MS; Baldacci C; Garibaldi S; Flamini M; Sanchez AM; Gadducci A; Genazzani AR; Simoncini T
PLoS One; 2008 Jul; 3(7):e2790. PubMed ID: 18665217
[TBL] [Abstract][Full Text] [Related]
3. Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin.
Fu XD; Flamini M; Sanchez AM; Goglia L; Giretti MS; Genazzani AR; Simoncini T
Mol Hum Reprod; 2008 Apr; 14(4):225-34. PubMed ID: 18308736
[TBL] [Abstract][Full Text] [Related]
4. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.
Giretti MS; Fu XD; De Rosa G; Sarotto I; Baldacci C; Garibaldi S; Mannella P; Biglia N; Sismondi P; Genazzani AR; Simoncini T
PLoS One; 2008 May; 3(5):e2238. PubMed ID: 18493596
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
Perkins MS; Louw-du Toit R; Jackson H; Simons M; Africander D
Front Endocrinol (Lausanne); 2022; 13():959396. PubMed ID: 36187129
[TBL] [Abstract][Full Text] [Related]
6. 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin.
Zheng S; Huang J; Zhou K; Zhang C; Xiang Q; Tan Z; Wang T; Fu X
PLoS One; 2011; 6(7):e22439. PubMed ID: 21818323
[TBL] [Abstract][Full Text] [Related]
7. Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors.
Simoncini T; Fu XD; Caruso A; Garibaldi S; Baldacci C; Giretti MS; Mannella P; Flamini MI; Sanchez AM; Genazzani AR
Hum Reprod; 2007 Aug; 22(8):2325-34. PubMed ID: 17545686
[TBL] [Abstract][Full Text] [Related]
8. Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton.
Flamini MI; Fu XD; Sanchez AM; Giretti MS; Garibaldi S; Goglia L; Pisaneschi S; Tosi V; Genazzani AR; Simoncini T
J Cell Mol Med; 2009 Aug; 13(8B):2396-2407. PubMed ID: 18798864
[TBL] [Abstract][Full Text] [Related]
9. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate.
Nilsen J; Brinton RD
Endocrinology; 2002 Jan; 143(1):205-12. PubMed ID: 11751611
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
He M; Cheng Y; Li W; Liu Q; Liu J; Huang J; Fu X
BMC Cancer; 2010 Apr; 10():170. PubMed ID: 20429915
[TBL] [Abstract][Full Text] [Related]
11. Effects of progesterone and medroxyprogesterone on actin remodeling and neuronal spine formation.
Sanchez AM; Flamini MI; Genazzani AR; Simoncini T
Mol Endocrinol; 2013 Apr; 27(4):693-702. PubMed ID: 23487486
[TBL] [Abstract][Full Text] [Related]
12. LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton.
Sanchez AM; Flamini MI; Russo E; Casarosa E; Pacini S; Petrini M; Genazzani AR; Simoncini T
Mol Cell Endocrinol; 2016 Dec; 437():22-34. PubMed ID: 27502036
[TBL] [Abstract][Full Text] [Related]
13. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
14. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
Louw-du Toit R; Simons M; Africander D
J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
[TBL] [Abstract][Full Text] [Related]
15. New progestagens for contraceptive use.
Sitruk-Ware R
Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
[TBL] [Abstract][Full Text] [Related]
18. Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors.
Hussain R; El-Etr M; Gaci O; Rakotomamonjy J; Macklin WB; Kumar N; Sitruk-Ware R; Schumacher M; Ghoumari AM
Endocrinology; 2011 Oct; 152(10):3820-31. PubMed ID: 21828184
[TBL] [Abstract][Full Text] [Related]
19. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
20. Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton.
Giretti MS; Montt Guevara MM; Cecchi E; Mannella P; Palla G; Spina S; Bernacchi G; Di Bello S; Genazzani AR; Genazzani AD; Simoncini T
Front Endocrinol (Lausanne); 2014; 5():80. PubMed ID: 24904530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
